These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35841781)
1. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone. Lawal B; Kuo YC; Rachmawati Sumitra M; Wu ATH; Huang HS Comput Biol Med; 2022 Sep; 148():105814. PubMed ID: 35841781 [TBL] [Abstract][Full Text] [Related]
2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
3. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094 [TBL] [Abstract][Full Text] [Related]
4. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host. Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744 [TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients. Chen Y; Qin Y; Fu Y; Gao Z; Deng Y Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339 [TBL] [Abstract][Full Text] [Related]
6. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs. Park A; Harris LK Front Immunol; 2021; 12():694355. PubMed ID: 34367154 [TBL] [Abstract][Full Text] [Related]
7. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays. Curreli F; Ahmed S; Victor SMB; Drelich A; Panda SS; Altieri A; Kurkin AV; Tseng CK; Hillyer CD; Debnath AK Viruses; 2021 Dec; 14(1):. PubMed ID: 35062273 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
12. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H Elife; 2020 Apr; 9():. PubMed ID: 32338605 [TBL] [Abstract][Full Text] [Related]
13. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775 [TBL] [Abstract][Full Text] [Related]
14. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2. Patil AM; Göthert JR; Khairnar V Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930 [TBL] [Abstract][Full Text] [Related]
15. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome. Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L mBio; 2020 Sep; 11(5):. PubMed ID: 32978313 [TBL] [Abstract][Full Text] [Related]
16. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients. Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405 [TBL] [Abstract][Full Text] [Related]
17. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Yuan S; Chan JFW; Chik KKH; Chan CCY; Tsang JOL; Liang R; Cao J; Tang K; Chen LL; Wen K; Cai JP; Ye ZW; Lu G; Chu H; Jin DY; Yuen KY Pharmacol Res; 2020 Sep; 159():104960. PubMed ID: 32473310 [TBL] [Abstract][Full Text] [Related]
18. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives. Zhu Q; Xu Y; Wang T; Xie F Front Immunol; 2022; 13():1053437. PubMed ID: 36505489 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Ketenci S; Uygar Kalaycı M; Dündar B; Duranay R; Şükrü Aynacıoğlu A Int Immunopharmacol; 2022 Sep; 110():108939. PubMed ID: 35717836 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders. Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]